As AI tools move from experimental use into clinical practice—helping with imaging interpretation, genetic diagnosis, and drug discovery—what evidence is emerging about their real impact on patient outcomes versus the risks of over-reliance or diagnostic errors?

Savannah, Georgia Correspondent In port logistics, we talk about throughput because ships have to move, cargo has to be located, and somebody eventually has to get a container onto a truck. A port that leaves every vessel at anchor while managers admire a new scheduling system has not improved its operations. Yet the opposite mistake … Continue reading As AI tools move from experimental use into clinical practice—helping with imaging interpretation, genetic diagnosis, and drug discovery—what evidence is emerging about their real impact on patient outcomes versus the risks of over-reliance or diagnostic errors?

How should regulators respond to the spread of monkeypox without repeating the early-COVID pattern of mixed messages and uneven access to vaccine?

Gastonia, NC Correspondent — Say who is actually at risk, say it on Monday, and say the same sentence on Friday. That's the whole rule. The current outbreak is concentrated in a defined sexual network — overwhelmingly men who have sex with men — and it's spreading through close, sustained skin contact rather than through … Continue reading How should regulators respond to the spread of monkeypox without repeating the early-COVID pattern of mixed messages and uneven access to vaccine?

Will the opioid epidemic ultimately force a fundamental rethinking of both pharmaceutical regulation and criminal justice approaches to addiction?

Wheeling, West Virginia Correspondent — We lived this in real time. Entire communities were hollowed out while the rest of the country was still deciding whether it was a story. The companies that pushed the pills and the distributors that shipped absurd quantities into towns of four hundred people should have faced harder consequences years … Continue reading Will the opioid epidemic ultimately force a fundamental rethinking of both pharmaceutical regulation and criminal justice approaches to addiction?